New York State Common Retirement Fund’s Armata Pharmaceuticals ARMP Stock Holding History

New York State Common Retirement Fund’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$99.8K	Buy	+15,400	New	+$141K	﹤0.01%	2691

Other funds holding ARMP

MAM

Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

New York State Common Retirement Fund's ARMP Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Armata Pharmaceuticals (ARMP) in Q2 2026: 15,400 shares worth $99.8K. The stake represents ﹤0.01% of the portfolio and ranks #2691 among its holdings.

53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

New York State Common Retirement Fund held 15,400 shares of Armata Pharmaceuticals worth $99.8K as of Q2 2026.
Armata Pharmaceuticals was a new New York State Common Retirement Fund position in Q2 2026.
Armata Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2691 holding.
53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.